Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Novo Nordisk A/S
NVO | US
41.17
USD2.65
6.88%
NVO | US
Loading StockChartView...
About Novo Nordisk A/S
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
41.17
Open
40.06
High
41.23
Low
39.89
Novo Nordisk A/S a healthcare company engages in the research development manufacture and marketing of pharmaceutical products worldwide. It operates in two segments Diabetes and Obesity care and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins GLP-1 and related delivery systems oral antidiabetic products obesity glucagon needles and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia blood disorders endocrine disorders growth disorders and hormone replacement therapy. The company collaboration agreements with Gilead Sciences Inc. The company was founded in 1923 and is headquartered in Bagsvaerd Denmark.
View LessNVO | US
Risk
36.4
Sharpe
-0.66
Luna's Score
67/100
Recommendation
Buy
Luna says (NVO | US)
What's Working
Strength based on increasing price with high volume
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
What's not Working
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
44.2%1 month
36.4%3 months
60.9%6 months
54.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
40.44
Fwd. PE
29.59
Price to book
32.06
Debt to equity
0.51
Debt to assets
0.15
Ent. to EBITDA
27.10
Ent. to rev.
14.06
PEG
1.82
Other Fundamentals
EBITDA
126.56B
MarketCap
181.82B
MarketCap(USD)
181.82B
Div. yield
1.22
Op. margin
46.48
Erngs. growth
3.90
Rev. growth
25.30
Ret. on equity
88.57
Short ratio
1.82
Short perc.
0.22
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.46
Range1M
6.29
Range3M
29.04
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.50
Price X volume
989.11M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.10 | 0.53 | Expensive |
| Ent. to Revenue | 14.06 | 3,967.00 | Cheaper |
| PE Ratio | 40.44 | 41.03 | Par |
| Price to Book | 32.06 | 15.55 | Expensive |
| Dividend Yield | 1.22 | 2.20 | Poor |
| Std. Deviation (3M) | 60.93 | 72.80 | Par |
| Debt to Equity | 0.51 | -1.23 | Expensive |
| Debt to Assets | 0.15 | 0.25 | Cheaper |
| Market Cap | 181.82B | 3.66B | Market Leader |
